VAdriaC Regimen

Known as: VAdriaC, Vincristine-Adriamycin-Cyclophosphamide Regimen 
A regimen consisting of vincristine, doxorubicin and cyclophosphamide, used for the treatment of localized childhood Ewing's sarcoma.
National Institutes of Health

Topic mentions per year

Topic mentions per year

1993-2015
0119932015

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2015
2015
A 6-year-old boy initially presented to an outside hospital with a right orbital mass with biopsy positive for translocation… (More)
Is this relevant?
2009
2009
10024 Background: Children with cancer undergoing dose-intensive chemotherapy often require G-CSF support. Patients (pts) < 2 yrs… (More)
Is this relevant?
Review
2000
Review
2000
OBJECTIVE The authors describe the salient clinical, radiologic and histopathologic features of an extremely rare para-testicular… (More)
Is this relevant?
1996
1996
BACKGROUND This study was conducted to determine the feasibility of, and improve outcome by, incorporating ifosfamide and… (More)
Is this relevant?
1993
1993
PURPOSE In an effort to improve outcome in patients with metastatic or high-risk localized Ewing's sarcoma family of tumors (ESF… (More)
Is this relevant?